FDA Approves First Treatment for Geographic Atrophy, Pegcetacoplan (SYFOVRE)

FRIDAY, Feb. 24, 2023 -- Pegcetacoplan (SYFOVRE) has been approved by the U.S. Food and Drug Administration as the first and only treatment for geographic atrophy (GA), an advanced form of age-related macular degeneration. Pegcetacoplan is an...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news